» Articles » PMID: 8313318

Rising Incidence of Bronchioloalveolar Lung Carcinoma and Its Unique Clinicopathologic Features

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1994 Feb 15
PMID 8313318
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bronchioloalveolar lung carcinoma (BAC) is a unique type of lung cancer with distinguishing pathologic, biologic, epidemiologic, demographic, and perhaps etiologic features.

Methods: The authors investigated and analyzed all of the cases of pathologically confirmed BAC seen at our institution in the hope of discovering new or confirming known features of this disease.

Results: When cases of BAC expressed as a percentage of total lung cancers were analyzed in successive 5-year periods from 1955 to 1990, BAC rose from less than 5% to 24.0% (P < 0.001). Much of the increase in BAC occurred in women, as evidenced by a male-to-female ratio that wavered around unity. The mean age of BAC adenocarcinoma patients was 59.2 +/- 11.5 years, compared to 64.1 +/- 13.5 years for non-BAC adenocarcinoma (P < 0.05). BAC also contrasted with other forms of lung cancer by exhibiting a relatively high incidence of multifocality (25% versus 5%) (P < 0.001). There was an association between histologic subtype of BAC and pattern of pulmonic involvement. The mucinous subtype was more strongly associated with diffuse pulmonic involvement, and the sclerotic subtype was more strongly associated with multifocal involvement (P < 0.001). Furthermore, BAC cases exhibited a 20% incidence of dedifferentiation into patterns of poorly differentiated adenocarcinoma, a feature that was more associated with the mucinous and sclerotic subtypes (P < 0.05).

Conclusions: The emergence of BAC as a prominent type of lung cancer should stimulate new basic laboratory and case-control studies to elucidate further the natural history and etiology of this unique disease.

Citing Articles

Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma.

Kishikawa S, Hayashi T, Saito T, Takamochi K, Kohsaka S, Sano K Mod Pathol. 2020; 34(4):786-797.

PMID: 33024306 DOI: 10.1038/s41379-020-00690-w.


The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Cox M, Yang C, Speicher P, Anderson K, Fitch Z, Gu L J Thorac Oncol. 2017; 12(4):689-696.

PMID: 28082103 PMC: 5367982. DOI: 10.1016/j.jtho.2017.01.003.


Pulmonary tuberculosis masking lung cancer - A case report.

Dhandapani S, Dheenadayalu N, Shanmugam S, Amitkumar K, Reddy H Respir Med Case Rep. 2016; 16:35-7.

PMID: 26744649 PMC: 4681897. DOI: 10.1016/j.rmcr.2015.06.005.


Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA).

Kim C, Lee Y, Hung R, Boffetta P, Xie D, Wampfler J Cancer Epidemiol Biomarkers Prev. 2015; 24(12):1902-6.

PMID: 26503035 PMC: 4734370. DOI: 10.1158/1055-9965.EPI-15-0436.


Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.

Wang H, Schabath M, Liu Y, Berglund A, Bloom G, Kim J Clin Lung Cancer. 2015; 16(6):e141-63.

PMID: 26077095 PMC: 4609593. DOI: 10.1016/j.cllc.2015.05.007.